RxDoctor Payments Data

Zachary Cappello, MD

Otolaryngology · Charlotte, NCNPI 1295077014

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $15,000 of the $22,837 with a category attached, or 65.7%. Acclarent, Inc accounts for 83.5% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2022 at $10,181 and has fallen 86.3% since, to $1,394 in 2025. Among otolaryngology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$22,837in general payments, 2019–2025

Across 120 payments — averaging $190.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$19K
  • Sanofi$889
  • Stryker$643
  • Regeneron Healthcare Solutions, Inc.$410
  • Medtronic$396
  • Intersect ENT, Inc.$293
  • plus $1K from 17 others

What the payments were for

  • Consulting fees$15,00066%
  • Travel & lodging$2,58311%
  • Food & beverage$5,13422%
  • Education$1060%
  • Other$140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,837 in reported general payments places this provider in the 95th percentile of 362 otolaryngology providers in North Carolina.

See all otolaryngology providers in North Carolina

Medicare billing

Part B allowed, 2024
$172,213
Medicare patients
294
Services billed
1,520

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab15$55,907
Mometasone Furoate13$3,895
Ipratropium Bromide55$2,566
Azelastine Hcl44$1,465
Fluticasone Propionate65$1,238
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav71$554
Omeprazole37$419
Ondansetron OdtOndansetron36$265
Methylprednisolone35$227
Doxycycline Hyclate20$226
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen26$189
Famotidine15$185
Clindamycin Hcl16$157
Prednisone27$83

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →